November 18, 2010
By Edgar and Fax
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Fax: (202) 772-9198
Attn: Laura Crotty
| Re: | Helix BioMedix, Inc. |
| Form 10-K for the Fiscal Year Ended December 31, 2009 |
| Filed March 24, 2010 |
| File No. 033-20897 |
Ladies and Gentlemen:
On behalf of Helix BioMedix, Inc. (the “Company”), we submit this letter to you in connection with comments of the Staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) regarding the above-referenced filing, received by the Company by letter dated November 3, 2010. Per a telephone conversation on November 16, 2010 between Laura Crotty of the Staff and myself, this letter serves to advise the Staff that the Company expects to provide a response to the November 3, 2010 letter on or before December 3, 2010. Please do not hesitate to call me at (206) 676-7018 regarding this matter.
| Sincerely, |
SUMMIT LAW GROUP a professional limited liability company |
/s/ Cy Hersch |
Cy Hersch |